Form D · Other Health Care
Breakthrough Products, Inc.
Denver, CO · CIK 0001488401
Offering snapshot reported Feb 3, 2015 · SEC filing
- Reported sold
- $19.7M Offering amount: $19.7M
- Investors reported
- 24 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 4, 2014 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$11,903,845 → $19,726,857
- Reported investors15 → 24
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 3, 2015 | Amendment | $19,726,857 | $7,823,012vs Apr 17, 2014 | 24 | SEC filing |
| Apr 17, 2014 | Initial | $11,903,845 | No comparison | 15 | SEC filing |
| Oct 29, 2013 | Initial | $2,000,000 | No comparison | 2 | SEC filing |
| Apr 3, 2013 | Initial | $2,500,000 | No comparison | 10 | SEC filing |
| Feb 16, 2012 | Initial | $1,100,000 | No comparison | 2 | SEC filing |
| Dec 13, 2010 | Initial | $450,000 | No comparison | 2 | SEC filing |
| Sep 13, 2010 | Initial | $50,000 | No comparison | 2 | SEC filing |
| Jul 8, 2010 | Amendment | $1,032,500 | $0vs Jun 30, 2010 | 15 | SEC filing |
| Jun 30, 2010 | Amendment | $1,032,500 | $932,500vs Apr 1, 2010 | 15 | SEC filing |
| Apr 1, 2010 | Initial | $100,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-215829
Source: Form D, filed Feb 3, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Candace Crawford | Executive |
| Jordan Eisenberg | Director, Executive |
| Ron Fugate | Director |
| Ronald Fugate | Director |
| Randall Kaplan | Director |
| Robert King | Director |
| Philip Levin | Director, Executive |
| Dave Leyrer | Director |
| David T. Leyrer | Director |
| Lynne Millheiser | Executive |
| Eisenberg Noah | Director |
| Michael J. Valentino | Director, Executive |
| Mike Valentino | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
1610 Wynkoop Street Suite 300
Denver, CO, 80202
Denver, CO, 80202